Pramipexole is a medication used in the management and treatment of Parkinsonism and restless leg syndrome. It is in the anti-parkinsonian class of drugs. This activity describes pramipexole's indications, action, and contraindications as a valuable agent in managing parkinsonism and restless leg syndrome. In addition, this activity will highlight the mechanism of action, adverse event profile, and other key factors (e.g., off-label uses, dosing, pharmacodynamics, pharmacokinetics, monitoring, relevant interactions) pertinent to the interprofessional team members of patients with parkinsonism and restless leg syndrome.

**Objectives:**
- Identify the mechanism of action of pramipexole.
- Describe the potential adverse effects of pramipexole.
- Review the appropriate monitoring for patients receiving therapy with pramipexole.
- Outline some interprofessional team strategies for improving care coordination and communication to advance pramipexole and improve outcomes.